Management of brain metastases

Current Treatment Options in Neurology

Volumn 6, Issue 4, 2004, Pages 273-284

  Jeyapalan, Suriya A ^b   Batchelor, Tracy ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; CYTOTOXIC AGENT; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GADOLINIUM TEXAPHYRIN; METHOTREXATE; ONDANSETRON; TAXANE DERIVATIVE; TEMOZOLOMIDE; THALIDOMIDE; TRASTUZUMAB;

ANTINEOPLASTIC ACTIVITY; BONE MARROW SUPPRESSION; BRAIN METASTASIS; BREAST CANCER; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; CRANIOTOMY; DIGESTIVE SYSTEM CANCER; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG PENETRATION; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; HEAD AND NECK CANCER; HEADACHE; HUMAN; LEUKOPENIA; LIVER DISEASE; LONG TERM CARE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MELANOMA; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE CANCER; QUALITY OF LIFE; RADIOSENSITIVITY; REVIEW; STEREOTAXIC SURGERY; THROMBOCYTOPENIA; URINARY TRACT CANCER; WHOLE BODY RADIATION;

EID: 3142749062     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-004-0027-2     Document Type: Review

References (59)

1. Bernstein M, Berger MS: Neuro-Oncology: The Essentials. New York: Thieme Medical Publishers; 2000.
2. Yuile PG, Tran MH: Survival with brain metastases following radiation therapy. Australas Radiol 2002, 46:390-395.
3. Lutterbach J, Bartelt S, Ostertag C: Long-term survival in patients with brain metastases. J Cancer Res Clin Oncol 2002, 128:417-425.
4. Soffieti R, Ruda R, Mutani R: Management of brain metastases. J Neurol 2002, 249:1357-1369.
5. Gaspar L, Scott C, Rotman M, et al: Recursive Partitioning Analysis (RPA) of Prognostic Factors in Three Radiation Therapy Oncology Group (RTOG) Brain Metastases Trials. Int J Radiation Oncology Biol Phys 1997, 37:745-751.
6. Hoskin PJ, Brada M: Radiotherapy for brain metastases. Clin Oncol (R Coll Radiol) 2001, 13:91-94.
7. Sims E, Doughty D, Macaulay E, et al: Stereotactically delivered cranial radiation therapy: a ten-year experience of linac-based radiosurgery in the UK. Clin Oncol (R Coll Radiol) 1999, 11:303-320.
8. Sneed PK, Suh JH, Goetsch SJ, et al: A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of the brain metastases. Int J Radiat Oncol Biol Phys 2002, 53:519-526.
9. Shahidi H, Kvale PA: Long-term survival following surgical treatment of solitary brain metastasis in non-small cell lung cancer. Chest 1996, 109:271-276.
10. Delattre J-Y, Krol G, Thaler HT, Posner JB: Distribution of brain metastases. Arch Neurol 1988, 45:741-744.
11. Patchel R, Tibbs PA, Walsh JW, et al: A randomized trial trial of surgery in the treatment of single metastases to the brain. N Eng J Med 1990, 322:494-500.
12. Noordijk EM, Vecht CJ, Haaxma-Reiche HH, Padberg GW: The choice of treatment of single brain metastates should be based on extracranial tumor activity and age. Int J Rad Onc Biol Phys 1994, 29:711-717.
13. Mintz AH, Kestle J, Rathebone MP, et al.: A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996, 78:1470-1476.
14. Mintz AP, Cairncross JG: Treatement of a single brain metastasis: the role of radiation following surgical resection. JAMA 1998, 280:1527-1529.
15. Schackert G: Surgery of brain metastases: pro and contra. Onkologie 2002, 25:480-481.
16. Vecht CJ: Clinical management of brain metastasis. J Neurol 1998, 245:127-131.
17. Iwadate Y, Namba H, Yamaura A: Significance of surgical resection for the treatment of multiple brain metastases. Anticancer Res 2000, 29:753-578.
18. Bindal RK, Sawaya R, Leavens ME: Surgical treatment of multiple brain metastases. J Neurosurg 1993, 79:210-216.
19. Hazuka MB, Burleson W, Stroud DN: Multiple brain metastses are associates with poor survival in patients treated with surgery and radiotherapy. J Clin Oncol 1993, 11:369-373.
20. Wen PY, Loeffler JS: Management of brain metastases. Oncology 1999, 13:941-961.
21. Wronski M, Arbit E: Resection of brain metastases from colorectal carcinoma in 73 patients. Cancer 1999, 85:1677-1685.
22. Arbit E, Wronski M, Burt M, Galicich JH: The treatment of patients with recurrent brain metastases. Cancer 1995, 76:765-773.
23. Patchell RA, Tibbs PA, Regine WF, et al.: Postoperative radiotherapy in the treatment of single metastases to the brain. JAMA 1998, 280:1485-1489.
24. Posner JB: Neurologic Complications of Cancer. Philadelphia: FA Davis; 1995.
25. Egawa S, Tukiyama I, Akine Y, et al.: Radiotherapy of brain metastases. Int J Radiat Oncol Biol Phys 1986, 12:1621-1625.
26. Borgelt B, Gelber R, Kramer S, et al.: The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980, 6:1-9.
27. Postmus PE, Haaxma-Reiche H, Gregor A, et al.: Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy: an EORTC phase II study. Radiother Oncol 1998, 46:29-31.
28. Glantz MJ, Choy H, Yee L: Prophylactic cranial irradiation in small cell lung cancer: rationale, and recommendations. Semin Oncol 1997, 24:477-483.
29. Roman D, Sperduto P: Neuropychologic effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys 1995, 31:983-998.
30. Largerwaard FJ, Levendag PC, Nowak PJCM, et al.: Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Rad Onc Biol Phys 1999, 43:795-803.
31. Sen M, Ayse S, Detingoz R, et al.: Prognostic factors in lung cancer with metastasis. Radiother Oncol 1998, 46:33-38.
32. Ellerhorst J, Strom E, McCutcheon I: Whole brain irradiation for patients with metastic melanoma: a review of 87 cases. Int J radiat Oncol Biol Phys 2001, 49:93-97.
33. Lentzsh S, Reichardt P, Weber F, et al.: Brain metastases in breast cancer: prognostic factors and management. Eur J Cancer 1999, 35:580-585.
34. Nakagawa K, Tago M, Terahara A, et al.: A single institutional outcome analysis of Gamma Knife radiosurgery for single or mutiple brain metastases. Clin Neurol Neurosurg 2000, 102:227-323.
35. Petrovich Z, Yu C, Giannotta SL, et al.: Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J Neurosurg 2002, 97:499-506.
36. Sanghavi SN, Miranpuri SS, Chapell R, et al.: Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 2001, 51:426-434.
37. Kondziolka D, Patel a, Lunsford LD, et al.: Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999, 45:427-434.
38. Kreth FW, Muacevic A, Siefert A: Stereotactic radiosurgery plus whole brain radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 2000, 47:850-851.
39. Nieder C: Stereotatic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 2000, 46:1081-1082.
40. Shaw EG: Radiotherapeutic management of multiple brain metastases: "3000 in 10" whole brain radiation is no longer a "no brainer." Int J Radiat Oncol Biol Phys 1999, 45:253-254.
41. Maor MH, Dubey P, Tucker SL, et al.: Stereotactic radiosurgery for brain metastases: result and prognostic factors. Int J Cancer 2000, 90:157-162.
42. Varlotto JM, Flickinger JC, Niranjan A, et al.: Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2003, 57:452-464.
43. Lagerwaard FJ, Levendag PC: Prognostic factors in patients with brain metastases. Forum (Genova) 2001, 11:27-46.
44. Arriagada R, Le Chevalier T, Borie F, et al.: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Nat Cancer Inst 1995, 87:83-90.
45. Gregor A, Cull A, Stephens RJ, et al.: Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicenter randomized trial: United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 1997, 33:1752-1758.
46. Auperin A, Arrigado R, Pignon J-P, et al.: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 1999, 34:476-484.
47. Meert AP, Paesmans M, Bergsman T, et al.: Prophylactic cranial irradiation in small cell lung cancer:a systematic review of the literature with meta-analysis. BMC Cancer 2001, 1:5.
48. Fonseca R, O'Neill BP, Foote RL, et al.: Cerebral toxicity in patients treated for small cell carcinoma of the lung. Mayo Clinic Proc 1999, 74:461-465.
49. Postmus PE, Smit EF: Chemotherapy for brain metastases of lung cancer: a review. Ann Oncol 1999, 10:753-759.
50. Fenner MH, Possinger K: Chemotherapy breast cancer brain metastases. Onkologie 2002, 25:474-479.
51. Batchelor T: Lymphoma of the Nervous System. Cambridge, UK: Butterworth-Heinemann; 2004
52. Batchelor T, Leahy N, Kaufman D: High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin's lymphoma. Clin Lymphoma 2001, 2:116-119.
53. Abrey LE, Christodoulou C: Temozolomide for treating brain metastases. Semin Oncol 2001, 28:34-42.
54. Christodoulou C. Bafaloukos D, Kosmidis P, et al.: Phase II study of Temozolomide in heavily pretreated cancer patients with brain metastases. Ann Oncol 2001, 12:249-154.
55. Antonadou D, Paraskevaidis M. Sarris G, et al.: Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 2002, 20:3644-3650.
56. Agarwala SS, Kirkwood JM: Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study. Cancer 2003, 97:121-127.
57. Margolin K, Atkins B, Thompson A, et al.: Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group. J Cancer Res Clin Oncol 2002, 128:214-218.
58. Carde P, Timmerman R, Mehta MP, et al.: Multicenter phase 1b/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases. J Clin Oncol 2001, 19:2074-2083.
59. Meyers CA, Smith JA, Bezjak A, et al.: Neurocognitive function and progession in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: result of a randomized phase III trial. J Clin Oncol 2004, 22:157-165.